Personalised healthcare will need to start with prevention to be truly successful and individual, it will move from disease management to health management which will change the cost structures and prevent loss of quality life and generate wealth.
In order to be effective in personalised medicine, and specifically prevention, the way therapy is approved and subsidised will need significant modernisation. Individual responsibility in risk reduction and cost sharing/insurance is foreseen to develop. The medical structures and citizen involvement will also need development to optimise the best use of the new possibilities.
Focus on research into new medicines and cutting-edge treatments is key and this will already in the shorter run create jobs – whether they be in research itself, education, design and manufacture of in-vitro products or within the pharmaceutical industry.